On ECHEMI
Home > Drugs > menopause
menopause
On June 14, 1994, a working conference on the progress of menopause research in the 1990s was held in Geneva. It was proposed to abandon menopause and recommend the use of perimenopause and menopausal transition periods. The regulations are as follows: ① Premenopause (pre-menopausal period): refers to the period of ovarian activity, including puberty to menopause. ② Menopause (menopausal): refers to the last menstruation in a woman's life, which is often determined in retrospect. ③ Postmenopause (postmenopausal period): refers to the entire period from menopause to the end of life. ④ Menopausal transitional period (menopausal transitional period): refers to the period before menopause, that is, a transition period from reproductive age to menopause, including the earliest appearance of menopausal trends in clinical or blood hormone levels (i.e., a sign of ovarian function decline) until the last menstruation. ⑤ Peri-menopausal period: refers to the period before and after menopause, including the period from when clinical or blood hormone levels begin to show signs of menopause (i.e., signs of ovarian function decline), to one year after the last menstrual period, i.e., the menopausal transition period plus one year after menopause.
Related Drugs
Estradiol valerate tablets/estradiol cyproterone acetate tablets combined packaging
Indication: This product is used in combination with progestins to establish an artificial menstrual cycle to supplement estrogen deficiency mainly related to natural or artificial menopause: vasomotor diseases (hot flashes), reproductive urinary tract nutritional diseases (vulvovaginal atrophy, dyspareunia, urinary incontinence) and mental diseases (sleep disorders, weakness). Prevent bone loss caused by primary or secondary estrogen deficiency.
Calcium Gluconate Lozenges
Indication: Used to prevent and treat calcium deficiency diseases such as osteoporosis, tetany, bone dysplasia, rickets, and as calcium supplement for children, pregnant and lactating women, menopausal women, and the elderly.
Manufacturer:

Weifang Zhongshi Pharmaceutical Co., Ltd.

Calcium Gluconate Lozenges
Indication: Used to prevent and treat calcium deficiency diseases such as osteoporosis, tetany, bone dysplasia, rickets, and as calcium supplement for children, pregnant and lactating women, menopausal women, and the elderly.
Manufacturer:

Jilin Yuren Pharmaceutical Co., Ltd.

Calcium Gluconate Lozenges
Indication: Used to prevent and treat calcium deficiency diseases such as osteoporosis, tetany, bone dysplasia, rickets, and as calcium supplement for children, pregnant and lactating women, menopausal women, and the elderly.
Manufacturer:

Weifang Zhongshi Pharmaceutical Co., Ltd.

Calcium Gluconate Lozenges
Indication: Used to prevent and treat calcium deficiency diseases such as osteoporosis, tetany, bone dysplasia, rickets, and as calcium supplement for children, pregnant and lactating women, menopausal women, and the elderly.
Manufacturer:

Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd.

Leuprorelin Acetate Microspheres for Injection
Indication: 1. Endometriosis; 2. For uterine fibroids accompanied by menorrhagia, lower abdominal pain, back pain and anemia, it can reduce the size of the fibroids and/or improve the symptoms; 3. Premenopausal breast cancer and estrogen receptor-positive patients; 4. Prostate cancer; 5. Central precocious puberty.
Leuprorelin Acetate Microspheres for Injection
Indication: 1. Endometriosis; 2. For uterine fibroids accompanied by menorrhagia, lower abdominal pain, back pain and anemia, it can reduce the size of the fibroids and/or improve the symptoms; 3. Premenopausal breast cancer and estrogen receptor-positive patients; 4. Prostate cancer; 5. Central precocious puberty.
Strontium ranelate dry suspension
Indication: Treat postmenopausal osteoporosis to reduce the risk of vertebral and hip fractures.
Strontium ranelate dry suspension
Indication: Treat postmenopausal osteoporosis to reduce the risk of vertebral and hip fractures.
Strontium ranelate dry suspension
Indication: Treat postmenopausal osteoporosis to reduce the risk of vertebral and hip fractures.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.